Considering that tumour sites impose distinct chemokine (e.g., CCL22, CCL28) and nutrient constraints compared with inflamed autoimmune tissues, integrating these contexts could broaden the translational relevance of our model to both malignancy progression and autoimmune disease. Here, CCL22 is linked to autoimmune disease.